Halozyme Therapeutics shares owned by LSV Asset Management
Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by LSV Asset Management
from 13F filings
Historical chart of LSV Asset Management investment in Halozyme Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Halozyme Therapeutics held by LSV Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Halozyme Therapeutics by LSV Asset Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $19M | 462k | 40.68 |
| 2023-12-31 | $17M | 462k | 36.96 |